861650
(+)-生物素 4-硝基苯酯
98%
别名:
4-硝基苯基 (+)-生物素酯, d-生物素对硝基苯酯, BNP
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C16H19N3O5S
化学文摘社编号:
分子量:
365.40
UNSPSC Code:
12352108
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
5795805
Assay:
98%
Form:
powder
产品名称
(+)-生物素 4-硝基苯酯, 98%
InChI key
YUDNXDTXQPYKCA-YDHLFZDLSA-N
SMILES string
[O-][N+](=O)c1ccc(OC(=O)CCCC[C@@H]2SCC3NC(=O)NC23)cc1
InChI
1S/C16H19N3O5S/c20-14(24-11-7-5-10(6-8-11)19(22)23)4-2-1-3-13-15-12(9-25-13)17-16(21)18-15/h5-8,12-13,15H,1-4,9H2,(H2,17,18,21)/t12-,13-,15-/m0/s1
assay
98%
form
powder
optical activity
[α]25/D +51°, c = 2 in DMF: AcOH (99:1)
mp
163-165 °C (lit.)
solubility
methanol: 25 mg/mL, clear, colorless to greenish-yellow
functional group
ester
nitro
thioether
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
(+)-生物素-4-硝基苯酯可用于在细胞蛋白摄取研究中制备生物素标记ARC（腺苷-寡聚精氨酸偶联物）衍生物。也可用于制备生物素化喹唑啉衍生物抑制VEGFR-2酪氨酸（血管内皮生长因子受体-2）激酶活性。(+)-生物素-4-硝基苯酯在Na[17O]H存在下，水解形成[17O2]生物素用于17O核磁共振波谱法分析蛋白-配体大复合物。
使用Synple自动合成平台(SYNPLE-SC002)实现自动化生物素标记
使用Synple自动合成平台(SYNPLE-SC002)实现自动化生物素标记
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Solid-State 17O NMR Spectroscopy of Large Protein-Ligand Complexes.
Zhu J, et al.
Angewandte Chemie (International Edition in English), 49(45), 8399-8402 (2010)
Eiichi Akiyama et al.
ESC heart failure, 7(3), 996-1006 (2020-04-12)
Changes in echocardiographic parameters and biomarkers of cardiac and venous pressures or estimated plasma volume during hospitalization associated with decongestive treatments in acute heart failure (AHF) patients with either preserved left ventricular ejection fraction (LVEF) (HFPEF) or reduced LVEF (HFREF)
Björn Redfors et al.
Circulation (2018-04-19)
Background -Elevated B-type natriuretic peptide (BNP) is reflective of impaired cardiac function and is associated with worse prognosis among
Isabel Amador-Martínez et al.
American journal of physiology. Renal physiology, 317(2), F275-F285 (2019-05-23)
Major cardiovascular events are a common complication in patients with chronic kidney disease (CKD). Endothelial dysfunction can contribute to the cardiovascular injury observed in CKD. Here, we used a rat model of acute kidney injury to CKD transition to investigate
Identification of the ability of highly charged nanomolar inhibitors of protein kinases to cross plasma membranes and carry a protein into cells.
Uri A, et al.
Bioorganic & Medicinal Chemistry Letters, 12(16), 2117-2120 (2002)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持